What attributes tend to nudge clinicians toward accepting AI into their work lives? Several, of course—but the most broadly determinative can be trimmed to just two. 

An international team of researchers is calling on healthcare AI proponents to be more mindful of the technology’s unsuitability across much of the developing world. 

For the study, researchers had five diabetes specialists judge precision AI tools developed from a large, longitudinal dataset of patients’ individually expressed needs. 

The FDA has approved the balloon-expandable Sapien 3 TAVR platform from Edwards Lifesciences for treating asymptomatic severe aortic stenosis. This is the first time the agency has approved any TAVR technology to be used in asymptomatic patients. 

Healthcare may finally have struck a healthy balance between AI hype and AI reality, according to a report from impartial observers who are also, indirectly at least, healthcare AI stakeholders.

AI shines in radiology when tasked with interpreting images of patients whose odds of illness are either very high or very low. In these cases, the technology could help mitigate burnout and supplement staffing. 

Pulsed field ablation was one of the biggest topics at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society. Medtronic, Johnson & Johnson MedTech, Boston Scientific, Abbott, Kardium and Field Medical all shared new data at the conference highlighting the safety and effectiveness of their advanced PFA technologies. 

The world is in the throes of an AFib pandemic, one that could potentially get worse in the years ahead due to population growth, economic hardships and rigid resource limitations. According to the Heart Rhythm Society, one way to effectively combat this issue is the development of more AFib Centers of Excellence.